Skip to main content

Table 2 Influence of variables on the 90d MoCA value

From: Bridging therapy is associated with improved cognitive function after large vessel occlusion stroke – an analysis of the German Stroke Registry

Variable Single linear regression Multiple linear regression
B (95% CI) p-value B (95% CI) p-value
MRS ≤ 2
 Bridging-therapy 2.01 (0.4–3.62) 0.015 2.39 (0.20–4.58) 0.033
 Sex    0.52 (−1.08–2.12) 0.526
 Age    −0.11 (−0.17−−0.04) 0.001
 Symptom-onset to admission    0.00 (−0.003–0.003) 0.842
 NIHSS at admission    -0.04 (−0.17–0.09) 0.551
 Smoking    −1.91 (−3.71--0.11) 0.038
 Atrial fibrillation    −0.60 (−2.71–1.51) 0.576
 Aspirin premedication    −0.5 (−2.48–1.49) 0.623
 Anticoagulation    1.91 (−1.23–5.05) 0.232
 ASPECT-Score    −0.25 (− 0.94–0.43) 0.46
 NIHSS at discharge    −0.09 (− 0.29–0.12) 0.405
MRS = 0
 Bridging-therapy 3.55 (0.78–6.31) 0.013 4.38 (0.67–8.08) 0.021
 Sex    0.58 (−2.1–3.26) 0.669
 Age    −0.07 (−0.21–0.07) 0.319
 Symptom-onset to admission    −0.003 (− 0.76–1.07) 0.721
 NIHSS at admission    −0.06 (− 0.24–0.13) 0.56
 Smoking    0.80 (−2.50–4.11) 0.63
 Dyslipidemia    2.49 (−0.28–5.27) 0.078
 Aspirin premedication    −2.28 (−5.41–0.86) 0.154
 Anticoagulation    −0.49 (−7.32–6.34) 0.881
 NIHSS at discharge    0.16 (−0.76–1.07) 0.721
  1. CI Confidence Interval